Unigestion Holding SA Sells 41,121 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Unigestion Holding SA reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 51.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 38,059 shares of the healthcare conglomerate’s stock after selling 41,121 shares during the quarter. Unigestion Holding SA’s holdings in UnitedHealth Group were worth $22,246,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cornerstone Wealth Management LLC boosted its stake in UnitedHealth Group by 5.3% in the second quarter. Cornerstone Wealth Management LLC now owns 1,964 shares of the healthcare conglomerate’s stock valued at $1,000,000 after buying an additional 98 shares in the last quarter. Redhawk Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at approximately $546,000. James J. Burns & Company LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at approximately $1,773,000. Meadow Creek Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 6.4% during the second quarter. Meadow Creek Wealth Advisors LLC now owns 2,355 shares of the healthcare conglomerate’s stock worth $1,199,000 after buying an additional 141 shares in the last quarter. Finally, Patrick M Sweeney & Associates Inc. boosted its holdings in shares of UnitedHealth Group by 4.9% during the 2nd quarter. Patrick M Sweeney & Associates Inc. now owns 1,991 shares of the healthcare conglomerate’s stock valued at $1,007,000 after acquiring an additional 93 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Truist Financial restated a “buy” rating and set a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. UBS Group decreased their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday. Finally, Morgan Stanley lowered their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $626.84.

UnitedHealth Group Price Performance

UNH stock opened at $565.39 on Wednesday. The company’s 50-day moving average is $586.36 and its 200-day moving average is $559.39. The stock has a market capitalization of $520.31 billion, a PE ratio of 36.83, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.56 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.